Clinical outcome in patients with metastatic colorectal cancer harboring KRAS p.G13D mutation treated with cetuximab. Background: The optimum number of retrieved lymph nodes following preoperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results